Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression
NCT06419439Phase 2Recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Dec 2025
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of ketamine in chronic low back pain (CLBP) and major depressive disorder (MDD) (3 arms), sponsored by VA Office of Research & Development. Primary endpoint: PROMIS Short Form v1.1 Pain Interference 6b. Started Dec 2025; status: recruiting.
02
Drugs
ketamine
03
Conditions
chronic low back pain (CLBP)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06419439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06419439.